Managed Healthcare Executive July 29, 2024
Nine of the 10 top specialty drugs by expenditure are biologics, according to the Pharmaceutical Strategies Group report on specialty drug spending.
Biologics are among the highest priced drugs, so even if they account for a relatively small proportion of the prescriptions, they have an outsize effect on drug expenditures.
The report on specialty drugs issued by the Pharmaceutical Strategies Group (PSG) last week adds just a bit more evidence to support this fundamental math about U.S. drug expenditures.
Although there is some shuffling among the rankings among them, 9 of the top 10 drugs by expenditure in 2023 were biologics, according to the report, which is based on datafrom PSG clients that allow their data to be used for...
Today's Sponsors
Today's Sponsor